Introduction {#Sec1}
============

With such an avalanche of reported cases of CoVID-19 (Coronavirus disease-19) from all across the globe, the family of Coronavirus has pretty nearly brought the entire human race under its feet since late December 2019 (Khan et al. [@CR11]). "Corona" loosely meaning "halo" or "crown" in Latin refers to the structure seen by the capsid and RNA. "Coronavirus" was actually termed during the imaging of the viral family Coronaviridae, due to the circular shape of the virus itself (Li [@CR19]). CoVID-19 is caused by the novel strain of Coronavirus named as SARS-CoV-2 due to its homology with SARS infection and has been declared as a pandemic by the WHO (World Health Organization) on March 2020 (World Health Organization [@CR31]). This novel strain of CoV debuted into the human host causing severe pneumonia and respiratory disorders (Wang et al. [@CR29]). SARS-CoV-2 has managed to rattle the host immune system very successfully. Reports suggest that, analogous to its predecessor (SARS-CoV), who belongs to the same genera and family, the origin of SARS-CoV-2 has also been reported to be from the species of bats (Li et al. [@CR22]). This strain of coronavirus is highly contagious, which is the root cause of CoVID-19 being spread rapidly and causing higher number of casualties ever since the first case has been reported.

Family of Coronaviruses {#Sec2}
=======================

Coronaviruses (CoVs) are a group of viruses that belong to the family *Coronaviridae*, infecting humans along with other species (not every CoVs), and are respiratory illness causing viruses. The first encounter with the CoV was seen in 1960s, which was named as HCoV-OC43 and HCoVs 229E (Drosten et al. [@CR6]). Until late December 2019, six such groups of CoVs were being known: HCoV-OC43, HCoV-HKU1, HCoV-229E, SARS-CoV, HCoV-NL63, and MERS-CoV are among them. CoVs are categorized under four genera: Alpha CoVs (HCoV-NL63, HCoV-229), Beta CoVs (HCoV-OC43, SARS-CoV, HCoV-HKU1, and MERS-CoV), Gamma CoVs, and Delta CoVs (Fehr and Perlman [@CR8]).

Entry of CoV into Host Cells {#Sec3}
============================

Coronaviruses uses a very spiky-shaped protein, S protein, to infect a cell by binding to the membrane of the cell. COVID-19 (SARS-CoV-2) and SARS-CoV share a receptor-binding unit whose domain structure is similar, suggesting that COVID-19 (SARS-CoV-2) uses ACE2 receptor in humans for infection (Yan et al. [@CR32]). The spike protein binds to this ACE2 receptor on the host cell surface and gets pinched inside the host cell. Studies has been conducted which shows the role of an enzyme Furin present in the host cells, plays a crucial role in SARS-CoV-2 entry, and can be a distinguishing feature defining the severity of SARS-CoV-2, since it is absent in SARS-CoV (Walls et al. [@CR27]). This enzyme activates SARS-CoV-2 whereas the SARS-CoV and MERS-CoV during entrance into the host cell do not encounter this activated site. Since furin is expressed in various human organs such as the lungs, small intestine, and liver, the infection in human has been seen to be very vigorous and can be predicted to be potentially infecting multiple human organs. This site could possibly affect the transmission as well as the stability of the virus.

Antigen Presentation During Human SARS-CoV-2 Infection {#Sec4}
======================================================

As an antiviral mechanism, antigen Presenting Cells (APC) are involve in the presentation of viral antigenic peptides in complexed with MHC (major histocompatibility complex) class I and class II molecules to CD8 and CD4 T cells. The selection of peptides and presentation technique of the host leads to a better understanding of cellular immunity and vaccine advancement. During any viral infection, DCs (dendritic cells) play a very important role as an APC. DCs are a linkage between innate and adaptive immunity. Studies deciphering the mechanism of antigen presentation during SARS-CoV-2 infection is not studied well therefore, the mechanism of antigen presentation can be understood based on the available data of predecessor strain infection (SARS-CoV & MERS-CoV) due to its analogy (Chen et al. [@CR4]). Because DCs are found in the respiratory tract and react back whenever there is an inflammation response, DCs are found to be a potential candidate in antigen presentation during SARS infection and also in understanding the immunopathology of SARS (Lau et al. [@CR16]).

During SARS infection, the upregulation of few chemokines such as IP-10 and MP1 is seen very significantly, also few of the antiviral cytokines are found to be low in expression such as IFN-alpha, IFN-beta, and IFN-gamma, and TNF-alpha and IL-6 are found to be at moderate upregulation (Kuri and Weber [@CR15]). Modulation of Toll-like receptors from TLR-1 to TLR-10 was seen to be at the same level; hence no modulation but chemokine receptors such as CCR5, CCR3, and CCR1 are found to be at significant level of upregulation (Law et al. [@CR17]). When similar type of study is conducted in patients infected with Middle East Respiratory Syndrome Coronavirus (MERS-CoV), it has been observed that this virus infects DCs very prolifically by inducing higher expression of IFN-gamma and even cytokines and chemokine related with IFN-gamma are found to be at a higher level. Altogether, antigen presentation in case of MERS-CoV-infected dendritic cells is seen to be significantly higher than in SARS-CoV-infected dendritic cells.

In case of SARS-CoV, the antigen presentation is done most importantly by MHC-I followed by MHC-II (Wieczorek et al. [@CR30]). Studies were done in human macrophages during SARS-CoV infection indicating an interesting observation that severe acute respiratory syndrome coronavirus infects human macrophages due to antibody enhancement (ADE) mediated by IgG. However, macrophages infected with SARS-CoV did not show productive viral replication (Yip et al. [@CR34]). MHC class II and I are further analyzed for epitope mapping which is one of the key steps towards vaccine development and which is studied intensively in case of SARS-CoV-2 infection (Sarkar et al. [@CR25]). Post MHC-I analysis, it was observed that the protein sequence of CoVID-19 is introduced by alleles of HLA-C rather than HLA-A and HLA-B (Prompetchara et al. [@CR24]). Alleles of HLA are studied in case of SARS-CoV infection and have been categorized into protection alleles (HLA-Cw1502, HLA-DR0301, and HLA-A∗0201) and susceptible alleles (HLA-B∗0703, HLA-Cw∗0801, HLA-DR B1∗1202, and HLA-B∗4601) (Wang et al. [@CR28]). In case of MERS-CoV infection, molecules of MHC class II, HLA-DQB1∗02:0, and HLA-DRB1∗11:01 are related with the susceptibility to infection (Fast and Chen [@CR7]; Hajeer et al. [@CR10]). While analyzing the viral genome of COVID-19 for epitope prediction, around 405 T cell epitopes have been determined which exhibits effective affinity towards MHC class I and II in addition two potent neutralizing epitopes (B cell epitope) based on Spike (S) protein were found (Fast and Chen [@CR7]).

Humoral Immune Response {#Sec5}
=======================

Humoral immune response is an antibody-mediated immune response. T helper cells assist B cells to differentiate into plasma cells, which in return produces antibodies (Abs) specific to a viral antigen (Ag). In order to limit infection, an antibody which is of neutralizing nature is efficient in fully blocking the virus from entering into host cells and hence plays a very intense protective role at a later stage of infection and also prevents relapse of infection in the future. In case of SARS-CoV, in order to enhance the humoral immune response, both B and T cell epitopes are being studied extensively and mapped for their structural as well as the envelope protein (S, N, M, E) (Channappanavar et al. [@CR2]). During the infection of SARS-CoV-2 it is studied and known that ACE2 (Angiotensin-Converting Enzyme 2) is the receptor present in the host cells and hence the site (B cell epitope site) wherein the Ab-binding site is located is a critical feature to be studied for a valuable insight (Yu et al. [@CR36]). It has been observed that SARS-CoV and 2019-nCoV spike proteins are similar in their major structural and T cell epitope (Kumar et al. [@CR14]).

In order to produce neutralizing Abs, both the proteins need to have B cell epitopes as their receptor binding domains (RBD). A very efficient T cell response has been found to be in relation with the production of higher neutralizing antibodies. T cell epitopes do not require a specific location in contrast to B cell epitopes; hence, it is located anywhere in viral protein. The helper T cell plays a role in isotype switching also and in case of SARS-CoV, the antibody profile of this virus produces IgM and IgG and at a later phase sero-conversion has been observed which is mediated by the helper T cells (Li et al. [@CR21]). IgM disappears at the end of week 12 whereas IgG has been found to last for a longer time pointing out to the probability of IgG being a potent protector Ab during the infection (Li et al. [@CR20]). Current evidence strongly indicates that Th1 type response is key to the successful control of SARS-CoV and MERS-CoV and probably true for SARS-CoV-2 as well (Yong et al. [@CR35]).

Cellular Immune Response {#Sec6}
========================

Cellular immune response is a mechanism of adaptive immunity. Cellular immunity in contrast to the humoral immune response can be seen inside the infected cells, which is mediated by T-lymphocytes. Helper T cells direct the overall adaptive immune response while cytotoxic T cells play a vital role in clearance and killing of viral infected cells. For any effective vaccine advancement, cellular immunity provided by T cells is very much essential as shown by the mouse model experiment on MERS-CoV and SARS-CoV (Yong et al. [@CR35]) wherein their reports suggested that the lack of T cells resulted in no viral clearance in infected mice, hence explaining the importance of T cells in viral infection (Lee et al. [@CR18]).

Referring back to the case of infection caused by Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus, it is reported that CD4^+^ (TNFα, IL-2, and IFN) and CD8^+^ (TNFα, IFNγ) memory T cells could persist in SARS-CoV-recovered patient for 4 years and can function by proliferating T cell, producing IFN-gamma, and by DTH response (Kuri and Weber [@CR15]). When investigated 14 out of 23 SARS-recovered patients, post 6 years of infection, it was reported that distinct T cell memory responded to the S library of peptide of SARS-CoV (Channappanavar et al. [@CR2]). Similar findings of distinct CD8^+^ T cells were seen during the case of MERS-CoV clearance in a mouse model too (Coleman et al. [@CR5]). Hence, this information can be useful in case of SARS-CoV-2 as well. However, in case of SARS-CoV-2 recent reports suggest that the PBMCs of SARS-CoV-2 infected individuals have shown efficient reduction in the CD8^+^ and CD4^+^ T cell counts, which may results in compromised T memory cell generation and persistence in SARS-CoV-2 survivors.

Cytokine Storm Syndrome in Patients Infected with SARS-CoV-2 {#Sec7}
============================================================

Cytokine storm syndrome is when there is a fatal blow up of cytokines due to over-reaction by the human body's immune system in response to an intruder. The *Lancet* has published a report on cytokine storm syndrome as being one of the causes of CoVID-19 severity (Coleman et al. [@CR5]). This report is backed up by the data on one of the major factors of death due to SARS-CoV-2 infection, which is acute respiratory distress syndrome (ARDS). ARDS has a significant relation with cytokine storm syndrome because, during ARDS, the immune effector cells have been shown to release huge amounts of chemokines and proinflammatory cytokines, which result in a fatal unconfined or uncontrolled systemic inflammatory response (Yao et al. [@CR33]). Previous pandemics caused by coronaviruses such as MERS-CoV and SARS-CoV have also shown such a massive release of chemokines and cytokines: in case of SARS-CoV, CCL2, CCL3, CCl5, CXCL8, CXCL9, CXCL10, etc. and IL-12, IL-18, IL-6, IL-1beta, IL-33, IFN-alpha, IFN-gamma, TNF- alpha & TGF-beta. In case of MERS-CoV, the elevation was seen in the levels of cytokines-IFN-α, IL-6, and chemokine such as CXCL-10, CCL-5, and CXCL-8 (Zheng et al. [@CR37]).

ARDS due to cytokine storm triggers a damaging attack to the body by the immune system causing failure of multiple organs subsequently and leads to death as reported in the case of SARS-CoV-2 outbreak which was the same as the cases of SARS-CoV and MERS-CoV infection reported previously. Lately, drugs targeting IL-18, IL-1, IL-6, and Interferon-gamma have been found effective in treating cytokine storm syndrome in other viral infections for the treatment and therefore may be used for the treatment of the COVID-19 patients for reducing the severity (Cameron et al. [@CR1]). However, one of such drugs falling under the same category, which blocks IL-6, has been reported to be efficient in a few cases of COVID-19 in China (Mehta et al. [@CR23]).

Immune Evasion Strategies for Coronaviruses {#Sec8}
===========================================

Human CoVs are the one of the most pathogenic viral infections that develops various immune evasion strategies. Studies have come up with reports supporting the fact that the family of CoVs are significantly able to suppress human immune responses by evading the immune detection mode smartly (Kikkert [@CR12]). This immune evasion property might explain longer incubation period, which is of 2--11 days, moderately, if not completely. Immune evasion helps them to efficiently dodge the detection by cellular PRRs of host immune response at the initial phase of infection. The three recent CoVs such as SARS-CoV, MERS-CoV, and SARS-CoV-2 share the same component of immune evasion method since all of them belong to the same genera, Betacoronavirus. The strategy of how these CoVs evades and regulates human immune responses has been a highly talked, studied, and evaluated topic for a very long time. Several studies have been carried out on SARS-CoV and MERS-CoV, which can also be referred in the case of SARS-CoV-2. During SARS-CoV infection, the isolation of viral dsRNA takes place inside the double membrane vesicles (DMVs), which is the probable shield of viral PAMPs from detection by cytosolic PRRs.

In order to exist and expand inside a host with inbuilt strong antiviral IFN immune responses, CoVs have been seen to employ different levels of strategies (Fig. [5.1](#Fig1){ref-type="fig"}) against the innate immune responses, especially type I IFN responses starting with the IFN signaling, induction of IFN, or antiviral action of ISG products (Channappanavar et al. [@CR3]). In any viral infection, interferons play the role of a very potent cytokine in order to control the infection. This suggests that CoVs play its smart game by interfering with the core system of IFN or it can also do so by destroying the key regulators.Fig. 5.1Immune escape mechanism by SARS-CoV. Coronavirus interferes with multiple steps during initial innate immune response including RNA sensing (1, 2), signaling pathways of type 1 IFN production (3), STAT ½ activation downstream of IFN/IFNAR (4)

Immune Escape Strategies {#Sec9}
========================

Inhibition of IFN Induction {#Sec10}
---------------------------

To understand this strategy briefly, both the CoVs, SARS-CoV and MERS-CoV, seem to be less generous regarding inducing IFN into most of the cell types. This less or delayed induction of IFN activates the proinflammatory cytokines and macrophages into the lungs and hence results in leakage of vascular vessels and also impairs the adaptive immune responses (Channappanavar et al. [@CR3]). Exceptional cell type wherein the IFN induction is at a relatively higher level is pDCs, which have shown to be expressing increased levels of Interferon alpha or beta (IFN-alpha & -beta) in case of disease caused by both MERS-CoV and SARS-CoV. This occurs through TLR7. Hence, TLR-like pathway could be a candidate for more core studies in case of SARS-CoV (Totura et al. [@CR26]). In case of MERS-CoV, the protein which inhibits IFN induction is seen to be ORF4a which interacts with dsRNA and the cofactor of RLR, PACT.

Inhibition of IFN Signaling {#Sec11}
---------------------------

From IFN docking to ISGF3, STAT1/STAT2/IRF9 complex mediated upregulation of ISGs, SARS-CoV and MERS-CoV act by interfering with the signal transduction chain with the help of several proteins. ORF3a protein and ORF6 protein are reported to decrease the IFNAR levels by proteolytic degradation and ubiquitination and by disrupting STAT1 nuclear import, respectively (Kopecky-Bromberg et al. [@CR13]; Frieman et al. [@CR9]). The ORF4a protein also inhibits IFN induction and hence moderates the ISG expression. The immune evasion strategy also evades adaptive immune responses during infection with SARS-CoV and MERS-CoV wherein T cell activation is diminished by downregulating antigen presentation by MHC I and II molecules.

Conclusions {#Sec12}
===========

The emergence and outbreak caused by SARS-CoV-2 is determined by the disruption of the host immune system by the virus. The virus strain has been observed to disturb the immune system by evasion of the immune response when a person is infected. It is on the safer side to predict that coronaviruses, having the biggest RNA genome so far, do not depend upon sole harmfulness factors; however they utilize a few layers of hostile to IFN procedures such as factors which include the type of virus, the titer of virus, and the load of virus. Else they would not have the strategy to exist, and even expand or mutate to a newer territory with strong antiviral IFN reactions (host). With just their genetic blueprint made available so far, it has become difficult for all research groups to identify the potential molecular targets of the virus. Immunopathology studies of disease caused by SARS-CoV-2 are still being investigated globally. However, with reference to the studies done so far on its predecessor infection, it can be concluded that few of the mechanisms which explain the severity of the disease caused by SARS-CoV-2 is the enzyme Furin, which is found at its activation site, and the mechanism of cytokine storm and immune evasion.

Future Perspectives {#Sec13}
===================

There are many hurdles in designing a vaccine against CoVID-19 due to the fact that different age group and individuals with pre-existing conditions react differently to this disease because of their differences in immune responses, which is why one-size vaccine will not be enough but still research groups are indulged in screening vaccine and the current vaccine candidate used is an antigen of the spike protein of coronavirus. Due to the lack of many failed antiviral strategies in order to efficiently treat infections by coronavirus, scientists are trying to come up with preventive measure such as vaccination. Taking into account the previous cases of coronavirus infection such as the infection of SARS-CoV and MERS-CoV, research groups have managed to come up till the stage of clinical trials of few vaccines and which is an advancement when it comes to the fight against such outbreaks. Hence, it will pave the way for some advancement in designing drugs and vaccine against CoVID-19 too. This is possibly a positive outcome for the vaccine candidate for SARS-CoV-2 disease in the future.
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